Department of Obstetrics and Gynecology, Shin-Kong Wu Ho-Su Memorial Hospital, Taipei 111, Taiwan.
Department of Obstetrics and Gynecology, National Yang-Ming University, Taipei 112, Taiwan.
Int J Mol Sci. 2020 Oct 31;21(21):8147. doi: 10.3390/ijms21218147.
Polycystic ovary syndrome (PCOS) is a common endocrinopathy, characterized by chronic anovulation, hyperandrogenism, and multiple small subcapsular cystic follicles in the ovary during ultrasonography, and affects 5-10% of women of reproductive age. PCOS is frequently associated with insulin resistance (IR) accompanied by compensatory hyperinsulinemia and, therefore, presents an increased risk of type 2 diabetes mellitus (DM). The pathophysiology of PCOS is unclear, and many hypotheses have been proposed. Among these hypotheses, IR and hyperandrogenism may be the two key factors. The first line of treatment in PCOS includes lifestyle changes and body weight reduction. Achieving a 5-15% body weight reduction may improve IR and PCOS-associated hormonal abnormalities. For women who desire pregnancy, clomiphene citrate (CC) is the front-line treatment for ovulation induction. Twenty five percent of women may fail to ovulate spontaneously after three cycles of CC treatment, which is called CC-resistant PCOS. For CC-resistant PCOS women, there are many strategies to improve ovulation rate, including medical treatment and surgical approaches. Among the various surgical approaches, one particular surgical method, called laparoscopic ovarian drilling (LOD), has been proposed as an alternative treatment. LOD results in an overall spontaneous ovulation rate of 30-90% and final pregnancy rates of 13-88%. These benefits are more significant for women with CC-resistant PCOS. Although the intra- and post-operative complications and sequelae are always important, we believe that a better understanding of the pathophysiological changes and/or molecular mechanisms after LOD may provide a rationale for this procedure. LOD, mediated mainly by thermal effects, produces a series of morphological and biochemical changes. These changes include the formation of artificial holes in the very thick cortical wall, loosening of the dense and hard cortical wall, destruction of ovarian follicles with a subsequently decreased amount of theca and/or granulosa cells, destruction of ovarian stromal tissue with the subsequent development of transient but purulent and acute inflammatory reactions to initiate the immune response, and the continuing leakage or drainage of "toxic" follicular fluid in these immature and growth-ceased pre-antral follicles. All these factors contribute to decreasing local and systemic androgen levels, the following apoptosis process with these pre-antral follicles to atresia; the re-starting of normal follicular recruitment, development, and maturation, and finally, the normalization of the "hypothalamus-pituitary-ovary" axis and subsequent spontaneous ovulation. The detailed local and systematic changes in PCOS women after LOD are comprehensively reviewed in the current article.
多囊卵巢综合征(PCOS)是一种常见的内分泌疾病,其特征为慢性无排卵、高雄激素血症和超声下卵巢内多个小的囊状卵泡。它影响着 5-10%的育龄妇女。PCOS 常伴有胰岛素抵抗(IR),伴有代偿性高胰岛素血症,因此增加了患 2 型糖尿病(DM)的风险。PCOS 的病理生理学尚不清楚,提出了许多假说。在这些假说中,IR 和高雄激素血症可能是两个关键因素。PCOS 的一线治疗包括生活方式改变和体重减轻。体重减轻 5-15%可能改善 IR 和 PCOS 相关的激素异常。对于有生育要求的妇女,枸橼酸氯米酚(CC)是一线促排卵治疗药物。25%的妇女在 CC 治疗三个周期后仍无法自发排卵,称为 CC 抵抗性 PCOS。对于 CC 抵抗性 PCOS 妇女,有许多提高排卵率的策略,包括药物治疗和手术方法。在各种手术方法中,一种特殊的手术方法,称为腹腔镜卵巢打孔术(LOD),被提议作为一种替代治疗方法。LOD 的总自发排卵率为 30-90%,最终妊娠率为 13-88%。对于 CC 抵抗性 PCOS 妇女,这些益处更为显著。尽管手术中的和手术后的并发症和后遗症一直很重要,但我们认为,更好地了解 LOD 后的病理生理变化和/或分子机制可能为该手术提供依据。LOD 主要通过热效应介导,产生一系列形态和生化变化。这些变化包括在非常厚的皮质壁上形成人工孔、使致密坚硬的皮质壁松动、破坏卵巢卵泡,随之减少卵泡膜细胞和/或颗粒细胞的数量、破坏卵巢间质组织,随之引发短暂但化脓性和急性炎症反应,启动免疫反应,以及持续漏出或引流这些不成熟和生长停止的窦前卵泡中的“毒性”卵泡液。所有这些因素都有助于降低局部和全身雄激素水平,随后这些窦前卵泡发生细胞凋亡,导致闭锁;正常卵泡募集、发育和成熟重新开始,最终“下丘脑-垂体-卵巢”轴恢复正常,继而自发排卵。本文全面综述了 LOD 后 PCOS 妇女的局部和全身变化。
Cochrane Database Syst Rev. 2020-2-11
Cochrane Database Syst Rev. 2012-6-13
Cochrane Database Syst Rev. 2005-7-20
Cochrane Database Syst Rev. 2000
Cochrane Database Syst Rev. 2007-7-18
Cochrane Database Syst Rev. 2001
Curr Opin Obstet Gynecol. 2025-4-29
J Adv Res. 2024-11
Front Endocrinol (Lausanne). 2023
Life (Basel). 2023-5-28
Curr Opin Pediatr. 2020-10
Front Endocrinol (Lausanne). 2020-8-11
Int J Mol Sci. 2020-8-11
Medicine (Baltimore). 2020-7-24
Int J Mol Sci. 2020-8-6
Life (Basel). 2020-7-27
Reproduction. 2020-9
Ther Adv Endocrinol Metab. 2020-7-6